| RS2285981 |
NOTCH3
|
Health Risk |
Likely pathogenic |
Auditory neuropathy, Auditory neuropathy |
| RS2287616 |
ABCB11
|
Health Risk |
Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS2287617 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 2, ABCB11-related disorder |
| RS2287626 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1O |
| RS2288057 |
BBS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Retinal dystrophy |
| RS2288326 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Tibial muscular dystrophy |
| RS2288530 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, familial restrictive |
| RS2289181 |
CEP152
|
Health Risk |
Pathogenic |
— |
| RS2289292 |
TBX6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2289537 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS2290169 |
COPB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Baralle-Macken syndrome, Hepatocellular carcinoma |
| RS2291307 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Tibial muscular dystrophy |
| RS2291550 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1O, Hypertrichotic osteochondrodysplasia Cantu type |
| RS2293340 |
GUSB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 7, Hepatocellular carcinoma |
| RS2293417 |
SMARCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial meningioma |
| RS2293564 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS2293734 |
HGD
|
Health Risk |
Conflicting classifications of pathogenicity |
Alkaptonuria, Alkaptonuria |
| RS2294024 |
TG
|
Health Risk |
Pathogenic |
— |
| RS2294301 |
HAO1
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS2294305 |
HAO1
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS2294918 |
PNPLA3
|
Health Risk |
Conflicting classifications of pathogenicity |
NAFLD1, NAFLD1 |
| RS2295056 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS2295919 |
COL4A6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS229593 |
SPTB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Uterine corpus endometrial carcinoma |
| RS2295947 |
RSPH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 12 |
| RS2296166 |
GNPAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2296253 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS2296651 |
SLC10A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholanemia, familial |
| RS2296928 |
TRMT5
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 26, Combined oxidative phosphorylation defect type 26 |
| RS2297472 |
LIPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Lysosomal acid lipase deficiency, Wolman disease |
| RS2297599 |
ASS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrullinemia type I, Citrullinemia |
| RS2297669 |
ABCA4
|
Health Risk |
Pathogenic |
Stargardt disease, Retinal dystrophy |
| RS2297947 |
CHIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Chitotriosidase deficiency, Malignant tumor of esophagus |
| RS2301368 |
NOS2
|
Health Risk |
association |
repeat number of microsatellite, repeat number of microsatellite |
| RS2301560 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS2301600 |
MAG
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 75, Hereditary spastic paraplegia 75 |
| RS2301606 |
ADAMTSL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Geleophysic dysplasia 1, Geleophysic dysplasia 1 |
| RS2301703 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS2301734 |
WDR62
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2301833 |
CACNA1G
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 42, Inborn genetic diseases |
| RS2302022 |
GHRHR
|
Health Risk |
Pathogenic |
Isolated growth hormone deficiency, type 4 |
| RS2302172 |
NTHL1;TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, NTHL1-related disorder |
| RS2302296 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital multicore myopathy with external ophthalmoplegia, RYR1-related disorder |
| RS2302297 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, RYR1-related disorder |
| RS2302414 |
TTC19
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex III deficiency nuclear type 2, Lung cancer |
| RS2302691 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, Inborn genetic diseases |
| RS2303156 |
SCNN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Bronchiectasis with or without elevated sweat chloride 1, Liddle syndrome 1 |
| RS2303426 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2303603 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2303726 |
LTBP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies |
| RS2303783 |
CNGB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS2303790 |
CETP
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperalphalipoproteinemia 1, Hyperalphalipoproteinemia 1 |
| RS2303830 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2303834 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2304094 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS2304846 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS2305207 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1, Usher syndrome type 1D |
| RS2305795 |
P2RY11
|
Health Risk |
association |
Cataplexy and narcolepsy, Cataplexy and narcolepsy |
| RS2306058 |
ANKRD17
|
Health Risk |
association |
Lip and oral cavity carcinoma, Malignant lymphoma |
| RS2306234 |
BLK
|
Health Risk |
association |
Systemic lupus erythematosus, Systemic lupus erythematosus |
| RS2307109 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Congenital contractural arachnodactyly |
| RS2307293 |
MBD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2307347 |
MCM7
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2307429 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, POLG-related disorder |
| RS2307437 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, POLG-related disorder |
| RS2307440 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive sclerosing poliodystrophy |
| RS2307448 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Tip-toe gait |
| RS2307890 |
SYT14
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive spinocerebellar ataxia 11, Autosomal recessive spinocerebellar ataxia 11 |
| RS2309689 |
ACADVL
|
Health Risk |
Conflicting classifications of pathogenicity |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS231399 |
SH3BP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fibrous dysplasia of jaw, Fibrous dysplasia of jaw |
| RS2345056 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS2363337 |
VWF
|
Health Risk |
Pathogenic |
Hereditary von Willebrand disease, von Willebrand disease type 3 |
| RS237025 |
SUMO4;TAB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Type 1 diabetes mellitus 5, Diabetes mellitus type 1 |
| RS2395029 |
HCP5;HLA-B
|
Health Risk |
Conflicting classifications of pathogenicity |
Abacavir hypersensitivity, Autism spectrum disorder |
| RS2403254 |
LDHA
|
Health Risk |
association |
decreased blood alpha-hydroxyisovalerate levels, decreased blood alpha-hydroxyisovalerate levels |
| RS2405876 |
DHFR;MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2423326 |
HAO1
|
Health Risk |
association |
Nephrolithiasis, calcium oxalate |
| RS2432403 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS2435357 |
RET
|
Health Risk |
Benign; risk factor |
Hirschsprung disease, susceptibility to |
| RS243865 |
MMP2
|
Health Risk |
association |
Lip and oral cavity carcinoma, Lip and oral cavity carcinoma |
| RS2443637 |
SMPD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant lymphoma, large B-cell |
| RS2464034378 |
PHGDH
|
Health Risk |
Likely pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2464079458 |
PHGDH
|
Health Risk |
Likely pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2464080054 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2464092239 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2464111708 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2464112014 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2464112148 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2464114425 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2464114660 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2464115103 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2464155152 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2464159619 |
PHGDH
|
Health Risk |
Pathogenic/Likely pathogenic |
PHGDH deficiency, Neu-Laxova syndrome 1 |
| RS2464160831 |
PHGDH
|
Health Risk |
Pathogenic |
Neu-Laxova syndrome 1, Neu-Laxova syndrome 1 |
| RS2464161009 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2464170715 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2464187735 |
PHGDH
|
Health Risk |
Pathogenic/Likely pathogenic |
PHGDH deficiency, Neu-Laxova syndrome 1 |
| RS2464195 |
HNF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 3, Type 2 diabetes mellitus |
| RS2464195486 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |
| RS2464203249 |
PHGDH
|
Health Risk |
Pathogenic |
PHGDH deficiency, PHGDH deficiency |